Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California


MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services


MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica

BROOMFIELD, Colo., April 02, 2025 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its Nociscan product is now available in Santa Monica at Medical Imaging Center of Southern California (MICSC). Until now, MICSC has provided Nociscan exclusively at their Beverly Hills location.

“We are pleased to expand access to Nociscan in our Santa Monica location,” said Bradley Jabour, MD, founder of MICSC. “MICSC has a proud heritage of adoption of new and novel solutions that add value to our patients and referring physician customers. Nociscan has been an integral part of our Beverly Hills service offering and by adding it in Santa Monica we are expanding our services while replicating the benefits to patients and physicians currently provided in Beverly Hills. Physicians treating low back pain are constantly striving for more and better information when diagnosing and treating patients. Nociscan is helping physicians who treat low back pain and we are pleased to offer Nociscan at both our Los Angeles locations.”

In November 2024, Dr. Jabour was highlighted in an article about Nociscan in the Radiological Society of North America edition of MAGNETOM Flash, a peer-to-peer magazine published by Siemens Healthineers. The article features two physician-user perspectives on Nociscan, one from a spine surgeon and the other from Dr. Jabour’s point of view as a radiologist and imaging center owner.

Chronic low back pain (cLBP) is a global healthcare problem with approximately 266 million people worldwide suffering from degenerative spine disease and low back pain. Los Angeles is the most populous city in California, with an estimated population exceeding 3.8M people, and the second-most populous city in the United States, second only to New York City. Both Los Angeles and New York City are strategically important markets for Aclarion.

Aclarion’s Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Nociscan objectively quantifies chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient’s low back pain.

To find a Nociscan center, view our site map here.

For more information on Nociscan, please email: [email protected]

All organizations cited and/or quotes from individuals not part of Aclarion have reviewed and approved the contents herein.

About Aclarion, Inc.

Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient’s low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit www.aclarion.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Company’s current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as “anticipates,” “believes” and “expects” or similar expressions, are forward-looking statements. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. These and other risks and uncertainties are discussed more fully in our filings with the Securities and Exchange Commission. Readers are encouraged to review the section titled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as well as other disclosures contained in the Prospectus and subsequent filings made with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contacts:

Kirin M. Smith
PCG Advisory, Inc.
[email protected]

Media Contacts:

Jennie Kim
SPRIG Consulting
[email protected]



The Ensign Group Purchases Two Facilities in Washington

SAN JUAN CAPISTRANO, Calif., April 02, 2025 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that through subsidiaries of Standard Bearer Healthcare REIT, Inc., Ensign’s captive real estate company, it acquired the real estate to Emilie Court Assisted Living, a 60-unit senior living facility located in Spokane, Washington; and Mother Joseph Care Center, a 152-bed skilled nursing facility located in Olympia, Washington. Each of these facilities will be operated by a third-party operator and are subject to long term triple net leases. These acquisitions are two of eight buildings that Ensign agreed to purchase last year, some of which closed last month and some that will close in coming months.

“We are delighted to add these two facilities to Standard Bearer’s growing portfolio in the Northwest.” said Barry Port, Ensign’s Chief Executive Officer. “One of the purposes of Standard Bearer is that it provides us a pathway to acquire real estate portfolios and to operate the portions that are a fit for us as operators while also partnering with other talented operators that have a similar mission and values that we have. We are very excited to work together with our new tenant and look forward to completing similar transactions with them and others in the future.”

In a separate transaction on the same day, Ensign announced that it acquired the real estate and operations of Pacific Haven Subacute and Healthcare Center, a 99-bed skilled nursing facility located in Garden Grove, California. The real estate was acquired by a subsidiary of Standard Bearer and the business will be operated by an Ensign-affiliated tenant.

Ensign also acquired the operations of Alamitos West Health and Rehabilitation, a 142-bed skilled nursing facility, and Katella Senior Living Community, a 68-unit senior living facility. Both facilities are located in Los Alamitos, California and subject to a long-term, triple net lease with a third-party landlord.

These acquisitions are effective as of April 1, 2025, and bring Ensign’s growing portfolio to 343 healthcare operations, which includes 44 senior living operations, across 17 states. Ensign subsidiaries, including Standard Bearer, own 143 real estate assets. Mr. Port reaffirmed that Ensign is actively seeking opportunities to acquire real estate and to lease both well-performing and struggling skilled nursing, senior living and other healthcare related businesses throughout the United States.


About Ensign™

The Ensign Group, Inc.’s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 343 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. More information about Ensign is available at http://www.ensigngroup.net.


Contact Information

The Ensign Group, Inc., (949) 487-9500, [email protected]

SOURCE: The Ensign Group, Inc.



Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial

STAFFORD, Texas, April 02, 2025 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the following update on FLAMINGO-01 open label immune response data.

FLAMINGO-01 Immune Response Data Summary

The Company has analyzed the preliminary immune response data from FLAMINGO-01. Immune response data in both the HLA-A*02 treated and placebo arms and the third open label arm with all other HLA types (non- HLA-A*02), show that GLSI-100 is creating an immune response over time as the frequency of patients exhibiting an injection site reaction or GP2 Delayed-Type Hypersensitivity (DTH) skin test reaction as measured by induration or erythema is increasing with increased vaccinations.

  • The number of patients experiencing an immune response increased over time from baseline through the 4th to 6th month vaccinations in both HLA-A*02 and non-HLA-A*02 arms.
  • In addition, a baseline immune response to GP2 is being observed before any treatment with GP2 in both HLA-A*02 and non-HLA-A*02 arms. This result suggests that GP2 is a natural antigen, that may have been part of an immune response in the patient during prior trastuzumab or other treatments.
  • These two general immune response findings, immune response at baseline and increasing immune response over time, were also observed in the Phase IIb clinical trial for HLA-A*02 only patients. These results confirm that the HLA prevalence, safety, and immune response in FLAMINGO-01 patients is trending as expected in both HLA arms.
  • The Company recently filed patent claims for non-HLA-A*02 patients which may be solely owned by the Company separate from any prior license. These claims are also supported by binding prediction algorithms and in vitro binding experiments conducted by the Company. This represents an invention that was originated by the Company which could double the number of patients eligible for GP2 treatment to approximately 88,000 new patients per year in the US and Europe. The market potential using the drug prices per year of Kadcyla or Enhertu could be in the range of $8-10 billion per year.
  • As mentioned in a prior press release, the non-HLA-A02 types that are most commonly being enrolled in FLAMINGO-01 include HLA-A*03, HLA-A*24, HLA-A*01, HLA-A*11, HLA-A*68, HLA-A*29, HLA-A*30, HLA-A*23, and HLA-A*33.

Analysis of the open label data from FLAMINGO-01 has been conducted in a manner that maintains the study blind. The open label immune response data is based on the patients enrolled to date in FLAMINGO-01 and is thus preliminary. While comparing any preliminary FLAMINGO-01 data to the Phase IIb clinical trial data may be possible, these preliminary results are not a prediction of future results and the results at the end of the study may differ.

CEO Snehal Patel commented, “We are very encouraged to see that the preliminary results from FLAMINGO-01 show immune responses in both HLA-A*02 and non-HLA-A*02 patients. We are now considering the merits of adding a randomized placebo arm for non-HLA-A*02 patients, transforming this current open label third arm into effectively a second pivotal and blinded Phase III trial. If successful, the Company could pursue approval for both HLA-A*02 and non-HLA-A*02 patients in similar time frames using independent or combined analysis of the two patient groups with the potential to double the market for GP2 to up to $10 billion in revenue per year.”

Mr. Patel added, “The Company may choose to expand its immune response analysis of GP2 specific T cells by sequencing the DNA of the T cells at baseline and after treatment with GP2. The T cell sequences can be compared to the immune response increases over time. Expansion into GP2 specific CAR-T cells could potentially become another platform technology to complement GP2 peptide treatment for non-responding higher risk patients. Blood samples have been collected at multiple timepoints for future T cell and immune response analysis.”

Previously Published Phase IIb Immune Response Data

In the prospective, randomized, single-blinded, placebo-controlled, multi-center (16 sites led by MD Anderson Cancer Center) Phase IIb clinical trial of HLA-A*02 breast cancer patients, 46 HER2/neu 3+ over-expressor patients were treated with GLSI-100, and 50 placebo patients were treated with GM-CSF alone. After 5 years of follow-up, there was an 80% or greater reduction in cancer recurrences in the HER2/neu 3+ patients who were treated with GLSI-100, followed, and remained disease free over the first 6 months, which we believe is the time required to reach peak immunity and thus maximum efficacy and protection. The Phase IIb results can be summarized as follows:

  • 80% or greater reduction in metastatic breast cancer recurrence rate over 5 years of follow-up compared to 20-50% reduction in recurrence rate by other approved products
  • Peak immune response at 6 months
  • No reported serious adverse events attributable to treatment
  • Well-tolerated safety profile

Full immunization was received in the Primary Immunization Series (PIS), which included the first 6 GLSI-100 injections over the first 6 months. The PIS elicited a potent immune response as measured by local skin tests and immunological assays. Further, booster injections given every 6 months prolonged the immune response, thereby providing longer-term protection. In the Phase IIb and three Phase I clinical trials, where 146 patients were treated, the GP2 immunotherapy was well tolerated, and there were no reported serious adverse events related to GLSI-100.

The Phase IIb immune response data in HLA-A*02 only patients was published at AACR in 2021 with the following findings:

  • GP2 immunotherapy generated GP2-specific immune responses leading to promising clinical benefit, thus supporting GP2’s mechanism of action.
  • Immune responses to GP2 were measured over time using a CD8 T cell dimer binding assay (Dimer Binding Assay) and GP2 DTH skin tests. GP2 immunity peaked at 6 months in HER2 3+ patients after they completed their first 6 immunizations, as measured by the Dimer Binding Assay. The data also shows that for the 2.5 years that the immune response was measured, the immunity was sustained and remained above baseline, resulting in a reduction in metastatic breast cancer recurrences.
  • Broad based immune response suggests that GP2 immunotherapy and Herceptin based products may also have the potential to treat low HER2 and other HER2 1-3+ expressing cancers in combination with trastuzumab or trastuzumab antibody drug conjugates.

About FLAMINGO-01 and GLSI-100

FLAMINGO-01 (NCT05232916) is a Phase III clinical trial designed to evaluate the safety and efficacy of GLSI-100 (GP2 + GM-CSF) in HER2 positive breast cancer patients who had residual disease or high-risk pathologic complete response at surgery and who have completed both neoadjuvant and postoperative adjuvant trastuzumab based treatment. The trial is led by Baylor College of Medicine and currently includes US clinical sites from university-based hospitals and cooperative networks with plans to expand into Europe and to open up to 150 sites globally. In the double-blinded arms of the Phase III trial, approximately 500 HLA-A*02 patients will be randomized to GLSI-100 or placebo, and up to 250 patients of other HLA types will be treated with GLSI-100 in a third arm. The trial has been designed to detect a hazard ratio of 0.3 in invasive breast cancer-free survival, where 28 events will be required. An interim analysis for superiority and futility will be conducted when at least half of those events, 14, have occurred. This sample size provides 80% power if the annual rate of events in placebo-treated subjects is 2.4% or greater.

For more information on FLAMINGO-01, please visit the Company’s website here and clinicaltrials.gov here. Contact information and an interactive map of the majority of participating clinical sites can be viewed under the “Contacts and Locations” section. Please note that the interactive map is not viewable on mobile screens. Related questions and participation interest can be emailed to: [email protected]

About Breast Cancer and HER2/

neu

Positivity

One in eight U.S. women will develop invasive breast cancer over her lifetime, with approximately 300,000 new breast cancer patients and 4 million breast cancer survivors. HER2 (human epidermal growth factor receptor 2) protein is a cell surface receptor protein that is expressed in a variety of common cancers, including in 75% of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels.

About Greenwich LifeSciences, Inc.

Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2 protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75% of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. Greenwich LifeSciences has commenced a Phase III clinical trial, FLAMINGO-01. For more information on Greenwich LifeSciences, please visit the Company’s website at www.greenwichlifesciences.com and follow the Company’s Twitter at https://twitter.com/GreenwichLS.

Forward-Looking Statement Disclaimer

Statements in this press release contain “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Greenwich LifeSciences Inc.’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including statements regarding the intended use of net proceeds from the public offering; consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section entitled “Risk Factors” in Greenwich LifeSciences’ Annual Report on Form 10-K for the year ended December 31, 2023 and other periodic reports filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Greenwich LifeSciences, Inc. undertakes no duty to update such information except as required under applicable law.

Company Contact

Snehal Patel
Investor Relations
Office: (832) 819-3232
Email: [email protected]

Investor & Public Relations Contact for Greenwich LifeSciences

Dave Gentry
RedChip Companies Inc.
Office: 1-800-RED CHIP (733 2447)
Email: [email protected]



Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ

Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ

TORONTO–(BUSINESS WIRE)–
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram Global”), the cannabis leader in Canada by market share, is pleased to announce its inaugural virtual investor event, the OG Investor Session, taking place on April 10, 2025, at 4pm EST. This online event offers investors a front-row seat to Organigram Global’s next chapter. Attendees will gain valuable insights into the Company’s growth trajectory, engage directly with leadership on key industry trends, and get a behind-the-scenes look at the innovation and strategy driving Organigram Global forward.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250402121386/en/

Register here to get exclusive access to this event on April 10 at 4pm EST via Zoom. Event access details will be shared upon registering.

“We’re excited to host our first-ever virtual investor event as a way to connect directly with our shareholders and the broader investment community,” said Beena Goldenberg, CEO of Organigram Global. “This is more than just a look at where we are today—it’s about sharing where we’re headed. From our strategic vision and financial performance to the innovation fueling our growth, attendees will gain a well-rounded understanding of what sets Organigram Global apart and how we’re building for the future.”

Hear directly from the leaders shaping Organigram Global’s success:

  • Beena Goldenberg – CEO, on the vision and market strategy
  • Greg Guyatt – CFO, on financial performance and growth trajectory
  • Borna Zlamalik – SVP of R&D and Innovation, on innovation
  • Hosted by Max Schwartz, Director of Investor Relations

Attendees will also have exclusive access to behind-the-scenes video tours of Organigram Global’s various facilities, along with the opportunity to engage directly with senior management during a live Q&A.

Trading on TSX/NASDAQ

Further to the Company’s news release dated March 26, 2025, the Toronto Stock Exchange (“TSX”) has approved the name change to “Organigram Global Inc.”.

The Company’s common shares will begin trading on TSX and NASDAQ effective at the opening of trading today under the new name and the current stock symbol “OGI”. As part of the name change, the common shares of the Company have been assigned new CUSIP 68617J100 and ISIN CA68617J1003 numbers, and the warrants of the Company have been assigned new CUSIP 68617J118 and ISIN CA68617J1185 numbers.

Organigram Global recently launched its new identity, visit the newly launched www.organigram.ca to know more.

About Organigram

Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator and processor . Through its recent acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverages markets. the US and Canadian cannabinoid beverages markets.

Organigram Global is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram Global has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, DEBUNK and Collective Project. Organigram Global operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Forward-Looking Information

This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information including expectations regarding market performance, involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram Global to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks disclosed in the Company’s most recent annual information form, management’s discussion and analysis, and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

For Media enquiries:

Megan McCrae, Senior Vice President – Global Brands and Corporate Affairs [email protected]

For Investor Relations enquiries:

Max Schwartz, Director of Investor Relations

[email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Other Manufacturing Other Retail Advertising Cannabis Communications Manufacturing Digital Marketing Retail Natural Resources

MEDIA:

Photo
Photo

iHeartMedia to Launch Slate of iHeartPodcasts in Asia

iHeartMedia to Launch Slate of iHeartPodcasts in Asia

New podcast slate, in partnership with Mammoth Media Asia, will focus on the development of content from across the region, with an initial emphasis on music, entertainment, sports and wellness, featuring high profile hosts from across Asia

NEW YORK & SINGAPORE–(BUSINESS WIRE)–
iHeartMedia, the No. 1 podcast network globally according to Podtrac announced today its plan to launch a slate of multi-language podcasts from high-profile hosts across the fast-growing Asian market. The push into the Asian Pacific (APAC) region will be in partnership with Mammoth Media Asia, who will spearhead the partnerships and production on the ground.

The Asia Pacific podcast market was valued at US $373.57 million in 2024 and is projected to grow at a CAGR of 30.2% to $3.1 billion value from 2024 to 2031, driven by rising internet penetration and increasing digital content consumption in China, Japan, India and South Korea according to Cognitive Market Research.

The influence of Asian culture has been growing rapidly around the world and the initial podcast slate will focus on presenting high-profile talent from across the Asian entertainment industries ranging from K-pop, to Bollywood, to China’s hip-hop scene and beyond. The podcasts will highlight the most exciting personalities, cultural trends and issues from the region featuring categories in music, entertainment, sports, wellness and business, and will be available in Asia and on the iHeartRadio app and everywhere podcasts are heard. The slate is expected to launch in June 2025.

In addition to producing original podcast content in Asia, this new partnership will also focus on extending the reach of iHeartPodcasts current catalogue of 800+ shows across Asia. iHeartMedia will work with premiere distribution platforms and partners to bring iHeartPodcasts extensive range of engaging and influential podcasts to the widest Asian audience, unlocking opportunities for advertisers and brands throughout the region.

“We’ve seen the strong growth of the Asian markets – both on a domestic level and with influence across global markets and we are excited to partner with Mammoth Media Asia to launch the first-ever slate of iHeartPodcasts developed in Asia,” said Conal Byrne, CEO of the iHeart Digital Audio Group. “We believe that together with Jonathan and Jay, we can develop groundbreaking audio content in Asia that can reach audiences around the world.”

Jonathan Serbin, co-founder of Mammoth Media Asia said: “We are thrilled to partner with iHeartMedia to develop and distribute world-class podcasts. Asian culture – including music, movies, TV drama, food and fashion — have become a major influence across the globe. We are excited to work with top talent and compelling storytellers to share their tales and experiences with a worldwide wide audience.”

Jay Faires, co-founder of Mammoth Media Asia added: “Podcasting across Asia has been growing rapidly over the last five years. It’s already a major force in the domestic audio markets and will continue to expand. We believe that by partnering with iHeart and accessing their unparalleled assets, distribution capabilities, reach, analytics and advertising network, we can become a significant part of this growing industry, enabling podcasters from Asia to access a worldwide audience.”

iHeartPodcasts produces thousands of shows across a wide variety of genres, that span every category from business, sports, spirituality and technology to entertainment, family, comedy and true crime – and everything in between.

Mammoth Media Asia was recently founded and launched by Jonathan Serbin and Jay Faires. Jonathan Serbin was most recently Co-President of Asia and CEO of Greater China of Warner Music, overseeing eleven counties / territories across the region and was formerly Head of Asia for Billboard. Jay Faires oversees The Wellness Agency (TWA) which works with the most important founders in wellness helping them scale their companies globally. He is a seasoned media executive and entrepreneur in the content business having successfully sold companies he founded and built to both The Walt Disney Company and Lionsgate.

About iHeartMedia, Inc.

iHeartMedia, Inc. (Nasdaq: IHRT) is the leading audio media company in America, with 90% of Americans listening to iHeart broadcast radio in every month. iHeart’s broadcast radio assets alone have a larger audience in the U.S. than any other media outlet; twice the size of the next largest broadcast radio company; and over four times the ad-enabled audience of the largest digital only audio service. iHeart is the largest podcast publisher according to Podtrac, with more downloads than the next two podcast publishers combined, has the most recognizable live events across all genres of music, has the number one social footprint among audio players, with seven times more followers than the next audio media brand, and is the only fully integrated audio ad tech solution across broadcast, streaming and podcasts. The company continues to leverage its strong audience connection and unparalleled consumer reach to build new platforms, products and services. Visit iHeartMedia.com for more company information.

iHeartMedia

Angel Aristone

[email protected]

KEYWORDS: North America United States Asia Pacific Singapore Southeast Asia New York

INDUSTRY KEYWORDS: Entertainment Communications General Entertainment Music Podcast Media

MEDIA:

Logo
Logo

KRISPY KREME® and Fruity PEBBLES™ Rock All-New Milk Glaze Doughnuts for Four Days Only

KRISPY KREME® and Fruity PEBBLES™ Rock All-New Milk Glaze Doughnuts for Four Days Only 

New flavor of iconic Original Glazed® Doughnut inspired by last sip of Fruity PEBBLES cereal bowl sweetness is available April 3-6 at Krispy Kreme shops

CHARLOTTE, N.C.–(BUSINESS WIRE)–
Krispy Kreme® and Fruity PEBBLES™ are teaming up to rock tastebuds with Krispy Kreme x Fruity PEBBLES Milk Original Glazed® Doughnuts, available for a limited time this Thursday through Sunday (April 3-6).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250402377164/en/

New flavor of iconic Original Glazed® Doughnut inspired by last sip of Fruity PEBBLES cereal bowl sweetness is available April 3-6 at Krispy Kreme shops

New flavor of iconic Original Glazed® Doughnut inspired by last sip of Fruity PEBBLES cereal bowl sweetness is available April 3-6 at Krispy Kreme shops

The Krispy Kreme x Fruity PEBBLES collaboration features Fruity Pebbles Milk Original Glazed® Doughnuts – a classic ring doughnut coated with Fruity Pebbles Milk flavored glaze, capturing the sweet, fruity-licious taste of post-cereal goodness.

“You might say that we’ve reached a new glaze innovation ‘bedrock’ with Krispy Kreme x Fruity PEBBLES Milk Original Glazed® Doughnuts,” said Dave Skena, Krispy Kreme Chief Growth Officer. “Every bite of this new, melt-in-your-mouth twist on our Original Glazed® will have you thinking you just put down the cereal spoon. So, don’t miss out, these doughnuts are here for only four days.”

“This collaboration perfectly combines the iconic signatures of both brands,” said Leah Broeders, Head of Licensing for Fruity PEBBLES. “We’ve brought the unmistakable, beloved Fruity PEBBLES flavor to Krispy Kreme’s famed Original Glazed® doughnut, creating a truly one-of-a-kind treat. It’s a Yabba-Dabba-Doo-licious mashup that delivers the playful spirit of PEBBLES and the melt-in-your-mouth magic of Krispy Kreme in every bite. But just like Fruity PEBBLES in your cereal bowl, it won’t last long!”

Krispy Kreme x Fruity PEBBLES Milk Original Glazed® Doughnuts are available in-shop and for pickup or delivery via Krispy Kreme’s app and website, individually and by the dozen. Throughout the doughnuts’ availability, guests can get a dozen for just $5 with the purchase of any dozen at regular price while supplies last, limit two per guest in-shop and one per online order using promo code PEBBLES. Visit krispykreme.com/locate/location-search#grocery to find a shop or retailer near you.

To learn more about Krispy Kreme x Fruity PEBBLES Milk Original Glazed® Doughnuts, visit www.krispykreme.com/promos/fruity-pebbles.

Share how Krispy Kreme x Fruity PEBBLES Milk Original Glazed® Doughnuts rock by using #KrispyKreme #FruityPEBBLES and tagging @krispykreme and @pebblescereal on social media.

About Krispy Kreme

Headquartered in Charlotte, N.C., Krispy Kreme is one of the most beloved and well-known sweet treat brands in the world. Our iconic Original Glazed® doughnut is universally recognized for its hot-off-the-line, melt-in-your-mouth experience. Krispy Kreme operates in 40 countries through its unique network of fresh doughnut shops, partnerships with leading retailers, and a rapidly growing digital business with more than 17,500 fresh points of access. Our purpose of touching and enhancing lives through the joy that is Krispy Kreme guides how we operate every day and is reflected in the love we have for our people, our communities, and the planet. Connect with Krispy Kreme Doughnuts at KrispyKreme.com and follow us on social: X, Instagram and Facebook.

About PEBBLES™

PEBBLES™ cereal rocks! Amazing flavors, crispy crunchy rice, and iconic characters all come together perfectly to create a timeless breakfast classic. Fruity, Cocoa, and our special limited- edition flavors have been making mornings more fun for kids and grown-ups alike for over 50 years. Since the first bowl of PEBBLES™ cereal was poured in 1971 to today, the brand has captured hearts and minds, growing in the process to become the No. 1 selling kids’ cereal brand with more than 1.4 billion bowls eaten annually.

One of the most revered cartoons of all time, The Flintstones aired from 1960-1966, and they have returned in countless specials and films. PEBBLES™ cereal, named for Fred and Wilma’s daughter, was the first brand ever created around a media character. For more information on PEBBLES™ cereal, visit www.postpebblescereal.com.

About Post Consumer Brands

Headquartered in Lakeville, Minn., Post Consumer Brands, a business unit of Post Holdings, Inc., is dedicated to providing people and their pets with delicious food choices for every taste and budget. The company’s portfolio includes beloved brands such as Honey Bunches of Oats®, PEBBLES™, Grape-Nuts® and Malt-O-Meal® cereal and Peter Pan® peanut butter, as well as Rachael Ray® Nutrish®, Kibbles ‘n Bits® and 9Lives® dog and cat food. As a company committed to high standards of quality and to our values, we are driven by one idea: To make lives better by making delicious food accessible for all. For more information about our brands, visit www.postconsumerbrands.com and follow us on LinkedIn for the latest news.

About Warner Bros. Discovery Global Consumer Products

Warner Bros. Discovery Global Consumer Products (WBDGCP), part of Warner Bros. Discovery’s Revenue & Strategy division, extends the company’s powerful portfolio of entertainment brands and franchises into the lives of fans around the world. WBDGCP partners with best-in-class licensees globally on award-winning toy, fashion, home décor and publishing programs inspired by the biggest franchises from Warner Bros.’ film, television, animation, and games studios, HBO, Discovery, DC, Cartoon Network, HGTV, Eurosport, Adult Swim, and more. With innovative global licensing and merchandising programs, retail initiatives, and promotional partnerships, WBDGCP is one of the leading licensing and retail merchandising organizations in the world.

Liv Rockett

[email protected]

KEYWORDS: United States North America Minnesota North Carolina

INDUSTRY KEYWORDS: Men Restaurant/Bar Other Retail Family Specialty Consumer Food/Beverage Teens Parenting Retail Other Consumer Women Seniors

MEDIA:

Photo
Photo
New flavor of iconic Original Glazed® Doughnut inspired by last sip of Fruity PEBBLES cereal bowl sweetness is available April 3-6 at Krispy Kreme shops
Photo
Photo
New flavor of iconic Original Glazed® Doughnut inspired by last sip of Fruity PEBBLES cereal bowl sweetness is available April 3-6 at Krispy Kreme shops
Logo
Logo

Atlanta Braves Holdings Acquires Six-Building ‘Pennant Park’ Office Complex Adjacent To The Battery Atlanta

Atlanta Braves Holdings Acquires Six-Building ‘Pennant Park’ Office Complex Adjacent To The Battery Atlanta

Acquisition Broadens Real Estate Asset Portfolio to Grow Enterprise Value

Property Totals 763,465 Square Feet, Situated on Approximately 34 Acres and Featuring Over 2,700 Parking Spaces

ATLANTA–(BUSINESS WIRE)–
Atlanta Braves Holdings, Inc. (Nasdaq: BATRA, BATRK) today announced the Braves Development Company’s acquisition of Pennant Park, a six-building office complex located at the intersection of I-75 and I-285 adjacent to The Battery Atlanta. Owned by Rubenstein Partners since 2017, Pennant Park features 763,465 square feet of office space situated on approximately 34 acres and includes over 2,700 parking spaces. The property currently has 24 industry-diverse tenants anchored by blue-chip organizations such as The Home Depot. The acquisition is immediately accretive given the strong credit of its tenants, occupancy of over 80% and the close proximity to our highly amenitized campus.

“This represents a strategic step in the growth of our real estate portfolio and creates a significant opportunity for Atlanta Braves Holdings to enhance the tenant experience while investing in the future of our growing community at The Battery Atlanta,” said Mike Plant, President & CEO of Braves Development Company. “Acquiring this adjacent property expands our footprint and positions us to capitalize on the interest we continue to see in The Battery Atlanta. Additionally, this will provide expanded parking for the approximately 9 million people who visit us each year.”

The acquisition of Pennant Park furthers our strategic goals of delivering value to our fans and shareholders and continues our innovative spirit in taking professional sports well beyond traditional boundaries. As the surrounding area of Truist Park and The Battery Atlanta continues to grow, we will continue to invest in opportunities that advance our core mission of delivering the best sports and entertainment experiences.

Adjacent to the Chattahoochee River National Park, Pennant Park is bordered by Interstate North Circle and Interstate North Parkway. The parcel is approximately 34 acres in size and will increase our existing land footprint by over 30%. With the addition of leasable office space, this purchase will also bring total available square footage to over 3 million square feet across our various properties. Pennant Park is comprised of two components, Pennant Commons and Pennant View:

  • Pennant Commons:
    • Pennant Commons consists of four office buildings (320, 340, 360, and 380) sitting on a 17-acre site centered around a vibrant, recently upgraded multipurpose communal plaza, known as The Quad.
    • The buildings are four to six stories and include surface and structured parking totaling over 1,700 spaces.
    • Buildings 320 and 340 are fully leased to The Home Depot, and buildings 360 and 380 are multi-tenanted and leased currently to 14 tenants.
  • Pennant View:
    • Pennant View consists of two office buildings (210 and 3100) sitting on a 17-acre site that are both multi-tenanted and feature multimedia lobbies that were upgraded between 2017 and 2019.
    • The buildings are six stories and include surface and structured parking totaling over 970 spaces.
    • Pennant View’s expansive site provides future opportunities for site densification, driven by the rapidly urbanizing trajectory of the area.

Additional features of the property include 24-hour security, on-site engineering, a 48-person conference center, two fitness centers, on-site car detailing services, two cafés, Social Kitchen tenant lounge and cafe, bocce ball court, putting green, multi-sport game court, helipad, lake with jogging trail, and a Cobb Community Transit System bus stop.

High-resolution map and video available here: https://www.dropbox.com/scl/fo/q76o662kj20w0qi1fybjj/AKoE39XbCcpECOCklCO2Nng?rlkey=mr4nmiqevtjmod077wsvrk1ne&st=cp076ntg&dl=0

About Atlanta Braves Holdings, Inc.

Atlanta Braves Holdings, Inc. (Nasdaq: BATRA, BATRK) consists of 100% of the ownership and voting interest in Braves Holdings, LLC, which is the owner and operator of the Atlanta Braves Major League Baseball Club and a real estate portfolio that includes the mixed-use development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club’s stadium, Truist Park.

Important Notice Regarding Forward-Looking Statements

This press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about business, product and marketing strategies, future financial performance and prospects, trends and any other matters that are not historical facts. The words “believe,” “estimate,” “expect,” “anticipate,” “intend,” “plan,” “strategy,” “continue,” “seek,” “may,” “could” and similar expressions or statements regarding future periods are intended to identify forward-looking statements, although not all forward-looking statements may contain such words. Where, in any forward-looking statement, we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but such statements necessarily involve risks and uncertainties and there can be no assurance that the expectation or belief will result or be achieved or accomplished. Given these uncertainties, we caution you not to place undue reliance on these forward-looking statements. The risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements, include, without limitation: ABH’s inability to replicate certain functions or the loss of benefits of contracts associated with the transition away from Liberty Media; ABH’s historical financial information not being representative of its future financial position, results of operations, or cash flows; ABH’s ability to recognize anticipated benefits from the split-off from Liberty Media; ABH’s ability to successfully transition responsibilities for various matters from Liberty Media to in-house or third party personnel and costs incurred in connection with operating as a standalone public company; ABH’s ownership, management and board of directors structure; ABH’s indebtedness and its ability to obtain additional financing on acceptable terms and cash in amounts sufficient to service debt and other financial obligations; ABH’s ability to realize the benefits of acquisitions or other strategic investments; the impact of inflation and weak economic conditions on consumer demand for products, services and events offered by ABH; the outcome of pending or future litigation or investigations; operational risks of ABH and its business affiliates with operations outside of the U.S.; ABH’s ability to use net operating loss and disallowed business interest carryforwards; ABH’s ability to comply with government regulations and potential adverse outcomes of regulatory proceedings; the regulatory and competitive environment in which ABH operates; potential changes in the nature of key strategic relationships with business partners, vendors and joint venturers; the achievement of on-field success and ability to develop, obtain and retain talented players; the impact of organized labor; the impact of the structure or an expansion of Major League Baseball; the level of broadcasting revenue that ABH and its subsidiaries receive; the impact of data losses or breaches or disruptions in ABH’s information systems and information system security; ABH’s processing, storage, sharing, use and protection of personal data; ABH’s ability to attract and retain qualified key personnel; the inherent risks in the real estate business, including, but not limited to, tenant defaults, potential liability related to environmental matters and liquidity of real estate investments; and the impact of geopolitical incidents, accidents, terrorist acts, pandemics or epidemics, natural disasters, including the effects of climate change, or other events that cause one or more events to be cancelled or postponed, are not covered by insurance, or cause reputational damage to ABH and its affiliates. These forward-looking statements speak only as of the date of this press release, and ABH expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statement contained herein to reflect any change in ABH’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Please refer to the publicly filed documents of ABH, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as may be updated by subsequent filings under the Securities Exchange Act of 1934, as amended, including Forms 10-Q and 8-K, for additional information about ABH and about the risks and uncertainties related to ABH’s business which may affect the statements made in this press release.

MEDIA CONTACT: Jennifer Giglio, [email protected]

INVESTOR RELATIONS CONTACT: Cameron Rudd, [email protected]

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property Baseball Other Communications Sports Entertainment Communications General Entertainment Other Construction & Property

MEDIA:

Logo
Logo

SolarWinds Unveils Next-Generation Solutions to Tackle Modern IT Operational Resiliency Challenges

SolarWinds Unveils Next-Generation Solutions to Tackle Modern IT Operational Resiliency Challenges

New capabilities integrate observability, incident response, service management, and AI automation capabilities designed to streamline IT and strengthen operational resilience

AUSTIN, Texas–(BUSINESS WIRE)–
SolarWinds (NYSE:SWI), a leading provider of simple, powerful, and secure observability and IT management solutions, today announced a major step forward in helping businesses achieve IT operational resilience. The latest enhancements across the SolarWinds portfolio integrate expanded capabilities across observability, incident response, service management, and AI-powered automation—empowering IT teams to navigate complex hybrid environments, accelerate issue resolution, and ensure business continuity in an increasingly complex hybrid IT landscape.

“One of the biggest concerns we hear from customers is how to stay resilient amid rapid technological advancements and economic pressures,” said Cullen Childress, Chief Product Officer at SolarWinds. “Every new wave of change—from digital transformation to generative AI—feels like a storm threatening their business. They need solutions that not only help them adapt but also strengthen their ability to thrive in the face of disruption.”

Solving the IT Operational Resiliency Challenge:

The evolving IT environments offer flexibility, scalability, and cost advantages, but they also introduce new levels of complexity. Many IT teams are overwhelmed by:

  • Alert overload – Excessive alerts and event noise obscure critical incidents.
  • Data silos – Fragmented data streams complicate root-cause identification.
  • Lengthy resolution processes – Inefficient workflows slow remediation and increase downtime risk.

IT incidents can be severe—disrupting services, impacting revenue, eroding customer trust, and damaging brand reputation.

The SolarWinds integrated portfolio of observability, incident response, and service management, powered by SolarWinds® AI, addresses these challenges by correlating alerts, improving decision-making, and accelerating issue resolution. This unified approach enhances performance, availability, and control across complex hybrid IT ecosystems to deliver unmatched operational resilience.

Key Enhancements Across the SolarWinds Portfolio:

Squadcast Incident Response

  • New to the SolarWinds portfolio, Squadcast Incident Response unites people, processes, and technology, providing a proactive, structured approach to incident response and resolution. Squadcast brings AI-powered alert isolation, on-call management, multi-source alert correlation, standardized runbooks, status pages, and Microsoft Teams® and Slack® integration for incident swarming, leading to faster issue identification so organizations can minimize downtime, reduce remediation time, and maintain operational resilience.

SolarWinds Observability

  • Now supports expanded hybrid IT awareness with deeper and broader single-pane-of-glass visibility across major cloud vendors, including GCP, AWS®, Azure®, and on-premises environments. These expanded capabilities help ensure a unified and detailed view of your entire hybrid IT environment, enabling proactive management and optimization.
  • The AI-powered Log Insights feature surfaces critical insights from large volumes of log data, identifying patterns, anomalies, and trends that might indicate potential issues. This aids in proactive problem resolution and improves operational resilience by detecting issues before they become major incidents.
  • Root Cause Assist leverages SolarWinds AI to help identify the underlying causes of problems or issues by analyzing data and providing rich, contextual insights. This function automates and accelerates the analysis of application performance issues.

SolarWinds Database Observability

  • Entering Tech Preview, SolarWinds AI Query Assist improves database queries by automatically analyzing query patterns and suggesting optimal query rewrites. This provides more accurate and efficient query optimization, helping DBAs improve efficiency and lower production costs caused by excessively long-running queries.

SolarWinds Service Desk

  • SolarWinds AI Runbook generation automates the manual and time-consuming task of compiling and formatting pre-written operational guides into new runbooks with standardized resolution processes that enhance operational efficiency and improve incident response times.
  • Data masking improves an organization’s compliance with governance and industry regulations of PII, PCI, and sensitive data by masking sensitive information and preventing inadvertent sharing.

“Learning and adapting, core pillars of operational resilience, have been at the heart of success for SolarWinds over the past 25 years,” said Sudhakar Ramakrishna, CEO of SolarWinds. “Our mission is to share that knowledge with our customers, equipping them with solutions that help them navigate the IT operational resiliency challenges of today and tomorrow’s dynamic IT landscape.”

Availability

The new enhancements to the SolarWinds portfolio are available now, with deployment options tailored to meet the needs of organizations of all sizes. Whether you’re a small business or a global enterprise, SolarWinds offers the flexibility to scale with your IT operations.

Discover how SolarWinds can transform your IT operations today by visiting solarwinds.com.

Connect with SolarWinds

#SWI

#SWIcorporate

#SWIproducts

About SolarWinds

SolarWinds (NYSE:SWI) is a leading provider of simple, powerful, secure observability and IT management software built to enable customers to accelerate their digital transformation. Our solutions provide organizations worldwide—regardless of type, size, or complexity—with a comprehensive and unified view of today’s modern, distributed, and hybrid network environments. We continuously engage with IT service and operations professionals, DevOps and SecOps professionals, and database administrators (DBAs) to understand the challenges they face in maintaining high-performing and highly available hybrid IT infrastructures, applications, and environments. The insights we gain from them, in places like our THWACK community, allow us to address customers’ needs now and in the future. Our focus on the user and our commitment to excellence in end-to-end hybrid IT management have established SolarWinds as a worldwide leader in solutions for observability, IT service management, application performance, and database management. Learn more today at www.solarwinds.com.

The SolarWinds, SolarWinds & Design, Orion, and THWACK trademarks are the exclusive property of SolarWinds Worldwide, LLC or its affiliates, are registered with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries. All other SolarWinds trademarks, service marks, and logos may be common law marks or are registered or pending registration. All other trademarks mentioned herein are used for identification purposes only and are trademarks of (and may be registered trademarks of) their respective companies.

© 2025 SolarWinds Worldwide, LLC. All rights reserved.

MEDIA CONTACTS:

Dillon Townsel

SolarWinds

Phone: +1-512-571-3455

[email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Software Networks Internet Artificial Intelligence Data Management Technology Apps/Applications Other Technology

MEDIA:

Logo
Logo

Autohome Inc. Issues 2024 ESG Report

PR Newswire


BEIJING
, April 2, 2025 /PRNewswire/ — Autohome Inc. (NYSE: ATHM; HKEX: 2518) (“Autohome” or the “Company”), the leading online destination for automobile consumers in China, today issued its 2024 Environmental, Social and Governance (“ESG”) report.

The report outlines Autohome’s comprehensive long-term ESG strategy, progress it has made in key areas including corporate governance, product responsibility, responsible management practices, talent development, sustainable operations, and impactful social welfare initiatives.

Mr. Quan Long, Chairman of Autohome, commented, “As we continue to drive innovation and growth, we remain firmly committed to fostering a sustainable automotive ecosystem. Through our relentless pursuit of excellence and dedication to environmental stewardship, we are proud to contribute to a greener, more resilient future for the industry and our communities.”

To view the report in full, please visit the website of investor relations of the Company or access the report at: https://autohomeinc.gcs-web.com//static-files/7d502176-018f-4460-9215-2c698bef16fb

About Autohome Inc.

Autohome Inc. (NYSE: ATHM; HKEX: 2518) is the leading online destination for automobile consumers in China. Its mission is to engage, educate and inform consumers about everything auto. Autohome provides occupationally generated content, professionally generated content, user-generated content, and AI-generated content, a comprehensive automobile library, and extensive automobile listing information to automobile consumers, covering the entire car purchase and ownership cycle. The ability to reach a large and engaged user base of automobile consumers has made Autohome a preferred platform for automakers and dealers to conduct their advertising campaigns. Further, the Company’s dealer subscription and advertising services allow dealers to market their inventory and services through Autohome’s platform, extending the reach of their physical showrooms to potentially millions of internet users in China and generating sales leads for them. The Company offers sales leads, data analysis, and marketing services to assist automakers and dealers with improving their efficiency and facilitating transactions. Autohome operates its “Autohome Mall,” a full-service online transaction platform, to facilitate transactions for automakers and dealers. Further, through its websites and mobile applications, it also provides other value-added services, including auto financing, auto insurance, used car transactions, and aftermarket services. For further information, please visit www.autohome.com.cn.

Safe Harbor Statement 

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will”, “expects”, “anticipates”, “future”, “intends”, “plans”, “believes”, “estimates” and similar statements. Statements that are not historical facts, including statements about Autohome’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement. Further information regarding these and other risks is included in Autohome’s filings with the SEC and announcements on the website of the Hong Kong Stock Exchange. All information provided in this press release is as of the date of this press release, and Autohome does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

In China:

Autohome Inc.
Investor Relations
Sterling Song
Investor Relations Director  
Tel: +86-10-5985-7483
E-mail: [email protected]

Christensen China Limited 
Suri Cheng
Tel: +86-185-0060-8364
E-mail:  [email protected]

 

Cision View original content:https://www.prnewswire.com/news-releases/autohome-inc-issues-2024-esg-report-302418037.html

SOURCE Autohome Inc.

New Intuit Small Business Growth Council Launched to Champion AI and Digital Transformation for Small Businesses in the UK

New Intuit Small Business Growth Council Launched to Champion AI and Digital Transformation for Small Businesses in the UK

Business leaders urge support for AI and digital tools in government’s growth strategy

LONDON–(BUSINESS WIRE)–Intuit Inc. (Nasdaq: INTU), the global financial technology platform that makes TurboTax, Credit Karma, QuickBooks, and Mailchimp, today announced the launch of the Intuit Small Business Growth Council (Council), a new initiative dedicated to empowering small businesses in the UK through AI and digital adoption.

The Council, which consists of 18 digitally-connected businesses, will amplify the voices of small businesses in shaping policies that drive innovation and economic growth. Despite clear evidence that digitally connected businesses are 2.4 times more likely to report higher productivity and 2.3 times more likely to see increased revenue, more than 25% of UK small businesses still don’t use basic digital tools.

Intuit will host a roundtable with the Council at the Department of Business and Trade today. Intuit CEO Sasan Goodarzi and The Rt Hon Jonathan Reynolds MP, Secretary of State for Business and Trade will lead the roundtable discussion with Small Business Council members: Afiya Titus, Co-founder, Coco Financial; Emma Thomson, Founder, Gemz by Emz; and James Vincent, Co-founder, Hot Source Creative.

As the UK government prioritises digital reform and AI adoption, the Intuit Small Business Growth Council will help ensure small businesses are at the heart of this transformation and given the consideration and support to access these tools. By championing policies that make AI and digital tools more accessible, the Council will help small businesses harness technology to drive growth and efficiency. Research shows that if the UK’s 1.1 million micro businesses doubled their uptake of AI technology, it could unlock a £16.6 billion productivity boost. The initiative underscores Intuit’s commitment to empowering small businesses with the tools, resources, and advocacy they need to thrive in the digital economy.

A Proven Model for Small Business Advocacy

The Intuit Small Business Growth Council builds on the success of the Intuit Small Business Council in the United States, which has helped drive meaningful policy changes. The US Council’s advocacy led to the introduction of the Small Business Technological Innovation Act (S.305). The bipartisan legislation would make explicit that loans backed by the US Small Business Administration (SBA) can be used to fund the adoption of digital tools and technology by small businesses.

The UK Council brings together entrepreneurs from diverse industries, ensuring a broad range of expertise and perspectives on the opportunities and challenges of digital adoption are brought to the table. Focused on advocacy by small businesses for small businesses, the Council will put their voices at the forefront of conversations with key policy makers across the UK.

The Council will focus on three core areas:

  1. Driving Digital Adoption – Helping more small businesses embrace digital tools by tackling barriers like cost and complexity. The Council will advocate for better support, incentives, and resources to ensure businesses can fully benefit from digital transformation.
  2. Simplifying Business Administration – Helping small businesses save time and reduce complexity by advocating for smarter, digital-first solutions. For example, Making Tax Digital (MTD) has already saved UK businesses up to £915 million, yet further improvements could unlock even greater efficiencies. The Council will champion efforts to streamline tax processes and cut administrative burdens, allowing small firms to focus on growth.
  3. Democratising Access to AI – Ensuring small businesses aren’t left behind in the AI revolution. The Council will work to make AI tools more accessible and practical for small businesses, while ensuring their voices are heard in key industry and policy discussions.

Sasan Goodarzi, CEO of Intuit, says: “When businesses succeed, communities and economies prosper. Together with the UK government’s focus on digital adoption, we can fuel the success of small businesses with the use of data and AI to automate and complete tasks and workflows, from lead to cash, helping every business thrive. I’m excited for the new Council to bridge this gap and help ensure that UK policies reflect the needs of these entrepreneurs who are critical to the UK economy.”

Secretary of State for Business and Trade, Jonathan Reynolds, said: “AI and digital tools can be game changers for small businesses’ productivity, but we know there are barriers which get in the way of wide-spread adoption, which is why Intuit’s Small Business Growth Council is so important. This Government is working with industry leaders, including groups like the SME Digital Adoption Taskforce, to develop practical solutions addressing these challenges, supporting small businesses to thrive, growing the economy and securing the UK’s future through our Plan for Change.”

Rose Sellman-Leava, Small Business Growth Council member and Co-Founder of Inclusive Futures UK, adds, “I’m incredibly honored to have been invited to become a member of the Intuit Small Business Growth Council. Technology plays a huge part in helping our business make the greatest impact, but too often, policies and support structures don’t reflect our realities. This Council will give small business owners a seat at the table, helping to make sure digital transformation is accessible, practical, and truly beneficial for businesses of all sizes.”

James Vincent, Small Business Growth Council member and Co-Founder of Hot Source Creative, says, “SMEs are eager to embrace digital tools and AI, but challenges like cost, complexity, and regulatory barriers often stand in the way. This Council is about ensuring small businesses aren’t left behind—we need real, practical support to unlock the full potential of digital transformation.”

Leigh Thomas, Vice President for Europe, the Middle East, and Africa (EMEA), at Intuit, says: “The Intuit Small Business Growth Council has the chance to build on lessons learned over the last few decades in making sure small business owners’ voices are heard in Westminster. Its members span some of the most tech-forward enterprises and the most cherished traditional businesses. All are eager to play their part in shaping the UK’s digital agenda.”

For more information about the Small Business Growth Council and its mission, visit the Intuit blog.

About Intuit

Intuit is the global financial technology platform that powers prosperity for the people and communities we serve. With approximately 100 million customers worldwide using products such as TurboTax, Credit Karma, QuickBooks, and Mailchimp, we believe that everyone should have the opportunity to prosper. We never stop working to find new, innovative ways to make that possible.

Media contacts:

For more information, contact [email protected]

KEYWORDS: North America United States Ireland United Kingdom Europe District of Columbia

INDUSTRY KEYWORDS: Software Finance Artificial Intelligence Small Business Accounting Professional Services Technology Fintech

MEDIA:

Logo
Logo